Algernon Pharmaceuticals Inc
CNSX:AGN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.055
0.12
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of AGN.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
|
| JP |
|
Fujifilm Holdings Corp
TSE:4901
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Algernon Pharmaceuticals Inc
Balance Sheet Decomposition
Algernon Pharmaceuticals Inc
| Current Assets | 554.5k |
| Cash & Short-Term Investments | 176.5k |
| Receivables | 17k |
| Other Current Assets | 361k |
| Non-Current Assets | 4.3m |
| Intangibles | 4.3m |
| Other Non-Current Assets | 28.7k |
| Current Liabilities | 2.2m |
| Accounts Payable | 2.2m |
Free Cash Flow Analysis
Algernon Pharmaceuticals Inc
| CAD | |
| Free Cash Flow | CAD |
Earnings Waterfall
Algernon Pharmaceuticals Inc
|
Revenue
|
0
CAD
|
|
Operating Expenses
|
-1.7m
CAD
|
|
Operating Income
|
-1.7m
CAD
|
|
Other Expenses
|
700
CAD
|
|
Net Income
|
-1.7m
CAD
|
AGN Profitability Score
Profitability Due Diligence
Algernon Pharmaceuticals Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
Score
Algernon Pharmaceuticals Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
AGN Solvency Score
Solvency Due Diligence
Algernon Pharmaceuticals Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Algernon Pharmaceuticals Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AGN Price Targets Summary
Algernon Pharmaceuticals Inc
Dividends
Current shareholder yield for AGN is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?